REYVOW- lasmiditan tablet

Reyvow by

Drug Labeling and Warnings

Reyvow by is a Prescription medication manufactured, distributed, or labeled by Eli Lilly and Company. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY

NDC: 0002-0265-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 50 mg

For oral use.

Each tablet contains 50 mg of lasmiditan.

Rx only

50 mg

Dispense enclosed Medication Guide to each patient.

Lilly

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY

NDC: 0002-0632-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 100 mg

For oral use.

Each tablet contains 100 mg of lasmiditan.

Rx only

100 mg

Dispense enclosed Medication Guide to each patient.

Lilly

INGREDIENTS AND APPEARANCE

REYVOW 
lasmiditan tablet

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 0002-0265
Route of Administration	ORAL	DEA Schedule	CV

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
lasmiditan (UNII: 760I9WM792) (lasmiditan - UNII:760I9WM792)	lasmiditan	50 mg

Inactive Ingredients
Ingredient Name	Strength
Microcrystalline cellulose (UNII: OP1R32D61U)
Starch, corn (UNII: O8232NY3SJ)
Croscarmellose Sodium (UNII: M28OL1HH48)
Sodium Lauryl Sulfate (UNII: 368GB5141J)
Magnesium Stearate (UNII: 70097M6I30)
Polyvinyl Alcohol, Unspecified (UNII: 532B59J990)
Titanium dioxide (UNII: 15FIX9V2JP)
Polyethylene Glycol 3350 (UNII: G2M7P15E5P)
Talc (UNII: 7SEV7J4R1U)
Ferrosoferric Oxide (UNII: XM0M87F357)

Product Characteristics
Color	gray (light gray)	Score	no score
Shape	OVAL (oval)	Size	9mm
Flavor		Imprint Code	L50;4312
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 0002-0265-04	1 in 1 CARTON	08/21/2020
1		4 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Export only		08/21/2020

REYVOW 
lasmiditan tablet

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 0002-0632
Route of Administration	ORAL	DEA Schedule	CV

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
lasmiditan (UNII: 760I9WM792) (lasmiditan - UNII:760I9WM792)	lasmiditan	100 mg

Inactive Ingredients
Ingredient Name	Strength
Microcrystalline cellulose (UNII: OP1R32D61U)
Starch, corn (UNII: O8232NY3SJ)
Croscarmellose Sodium (UNII: M28OL1HH48)
Sodium Lauryl Sulfate (UNII: 368GB5141J)
Magnesium Stearate (UNII: 70097M6I30)
Polyvinyl Alcohol, Unspecified (UNII: 532B59J990)
Titanium dioxide (UNII: 15FIX9V2JP)
Polyethylene Glycol 3350 (UNII: G2M7P15E5P)
Talc (UNII: 7SEV7J4R1U)
Ferrosoferric Oxide (UNII: XM0M87F357)
Ferric Oxide Red (UNII: 1K09F3G675)

Product Characteristics
Color	purple (light purple)	Score	no score
Shape	OVAL	Size	12mm
Flavor		Imprint Code	L100;4491
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 0002-0632-04	1 in 1 CARTON	08/21/2020
1		4 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Export only		08/21/2020

Labeler - Eli Lilly and Company (006421325)